175 related articles for article (PubMed ID: 36839551)
1. Immune cell expression patterns of CD39/CD73 ectonucleotidases in rodent models of cardiac arrest and resuscitation.
Aoki T; Wong V; Yin T; Nakamura E; Endo Y; Hayashida K; Robson SC; Nandurkar H; Diamond B; Kim SJ; Murao A; Wang P; Becker LB; Shinozaki K
Front Immunol; 2024; 15():1362858. PubMed ID: 38545102
[TBL] [Abstract][Full Text] [Related]
2. Purinergic Profiling of Regulatory T-cells in Patients With Episodic Migraine.
Nurkhametova D; Kudryavtsev I; Khayrutdinova O; Serebryakova M; Altunbaev R; Malm T; Giniatullin R
Front Cell Neurosci; 2018; 12():326. PubMed ID: 30319363
[No Abstract] [Full Text] [Related]
3. Regulatory role of CD39 and CD73 in tumor immunity.
Kaplinsky N; Williams K; Watkins D; Adams M; Stanbery L; Nemunaitis J
Future Oncol; 2024 Apr; ():1-14. PubMed ID: 38652041
[TBL] [Abstract][Full Text] [Related]
4. CD39 is expressed on functional effector and tissue resident memory CD8+ T cells.
Isaacs JF; Degefu HN; Chen T; Kleist SA; Musial SC; Ford MA; Searles TG; Lin CC; Skorput AGJ; Shirai K; Turk MJ; Zanazzi GJ; Rosato PC
bioRxiv; 2024 Mar; ():. PubMed ID: 38559200
[TBL] [Abstract][Full Text] [Related]
5. CD39 as a marker of pathogenic CD8+ T cells in cancer and other chronic inflammatory diseases.
Canale FP; Ramello MC; Montes CL
Oncoscience; 2018 Mar; 5(3-4):65-66. PubMed ID: 29854871
[No Abstract] [Full Text] [Related]
6. CD39/CD73/A2AR pathway and cancer immunotherapy.
Xia C; Yin S; To KKW; Fu L
Mol Cancer; 2023 Mar; 22(1):44. PubMed ID: 36859386
[TBL] [Abstract][Full Text] [Related]
7. A Prospective Study Investigating Immune Checkpoint Molecule and CD39 Expression on Peripheral Blood Cells for the Prognostication of COVID-19 Severity and Mortality.
Gambichler T; Rüth J; Goesmann S; Höxtermann S; Skrygan M; Susok L; Becker JC; Overheu O; Schmidt W; Reinacher-Schick A
Viruses; 2024 May; 16(5):. PubMed ID: 38793691
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cell therapy in diabetic foot ulcer: An updated comprehensive review.
Hetta HF; Elsaghir A; Sijercic VC; Akhtar MS; Gad SA; Moses A; Zeleke MS; Alanazi FE; Ahmed AK; Ramadan YN
Health Sci Rep; 2024 Apr; 7(4):e2036. PubMed ID: 38650719
[TBL] [Abstract][Full Text] [Related]
9. Elevated CD39+T-Regulatory Cells and Reduced Levels of Adenosine Indicate a Role for Tolerogenic Signals in the Progression from Moderate to Severe COVID-19.
Elsaghir A; El-Sabaa EMW; Zahran AM; Mandour SA; Salama EH; Aboulfotuh S; El-Morshedy RM; Tocci S; Mandour AM; Ali WE; Abdel-Wahid L; Sayed IM; El-Mokhtar MA
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139439
[TBL] [Abstract][Full Text] [Related]
10. Purinergic signaling during intestinal inflammation.
Longhi MS; Moss A; Jiang ZG; Robson SC
J Mol Med (Berl); 2017 Sep; 95(9):915-925. PubMed ID: 28547076
[TBL] [Abstract][Full Text] [Related]
11. Ectonucleotidase Modulation of Lymphocyte Function in Gut and Liver.
Savio LEB; Robson SC; Longhi MS
Front Cell Dev Biol; 2020; 8():621760. PubMed ID: 33553158
[TBL] [Abstract][Full Text] [Related]
12. The Role of Cluster of Differentiation 39 (CD39) and Purinergic Signaling Pathway in Viral Infections.
Elsaghir A; El-Sabaa EMW; Ahmed AK; Abdelwahab SF; Sayed IM; El-Mokhtar MA
Pathogens; 2023 Feb; 12(2):. PubMed ID: 36839551
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft-versus-host disease.
Geraghty NJ; Watson D; Sluyter R
Immunol Cell Biol; 2019 Jul; 97(6):597-610. PubMed ID: 30957314
[TBL] [Abstract][Full Text] [Related]
14. Alterations in CD39/CD73 axis of T cells associated with COVID-19 severity.
Dorneles GP; Teixeira PC; da Silva IM; Schipper LL; Santana Filho PC; Rodrigues Junior LC; Bonorino C; Peres A; Fonseca SG; Monteiro MC; Boeck CR; Eller S; Oliveira TF; Wendland EM; Romão PRT
J Cell Physiol; 2022 Aug; 237(8):3394-3407. PubMed ID: 35754396
[TBL] [Abstract][Full Text] [Related]
15. Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73
Ahmadi P; Hartjen P; Kohsar M; Kummer S; Schmiedel S; Bockmann JH; Fathi A; Huber S; Haag F; Schulze Zur Wiesch J
Cells; 2020 Jul; 9(8):. PubMed ID: 32707842
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
